Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxymetazoline and Energy-Based Therapy in Rosacea
NCT03380390Phase 4Completed
- Sponsor
- Aclaris Therapeutics, Inc.
- Start
- Dec 2017
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Mucinex Full Force Nasal Spray in rosacea, sponsored by Aclaris Therapeutics, Inc.. Started Dec 2017; status: completed.
02
Drugs
Mucinex Full Force Nasal Spray
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT03380390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03380390.